Comparing Safety and Efficacy of Irrigated Radiofrequency Catheter Ablation Versus Combined Cryoballoon and Catheter Ablation for Persistent Atrial Fibrillation

Kosmidou, Ioanna; Sumayin, Kyari; Deering, Thomas; Wickliffe, Andrew; Kanitpudi, Sricharan; Prater, Stephen; Dan, Dan
October 2013
JAFIB: Journal of Atrial Fibrillation;Oct/Nov2013, Vol. 6 Issue 3, p13
Academic Journal
Background :Catheter and cryoballoon ablation are established treatments for atrial fibrillation. Frequently, substrate modification of the left atrium is performed in patients with persistent AF or evidence of left atrial adverse remodeling. We compared one year outcomes of AF ablation with substrate modification utilizing radiofrequency catheter ablation (RFA) compared to a combination of cryoballoon ablation with radiofrequency catheter ablation (HAFA). Methods: Ablation for persistent AF was performed using stand-alone catheter ablation (RFA group, n=31) or cryoballoon for pulmonary vein isolation with RFA catheter ablation for substrate modification (HAFA group, n=21) and procedural and clinical outcomes were analyzed. Pulmonary vein isolation and LA substrate modification including creation of left atrial ablation lines and/or CFAEs was performed in all patients. Patients were followed for up to one year. A three- month blinding window was applied for analysis. Results: Clinical characteristics were similar between groups. Total procedure (244.15±64.7 vs 235.5±54.6, p=0.6) and fluoroscopy time (37±15.4 vs 29.5±15.7, p=0.96) were not different between the HAFA and RFA groups, respectively. Periprocedural complications were similar among groups. AF free survival was not significantly different between groups (p=0.631). Actuarial arrhythmia recurrence in one year was similar among groups (58.1% vs 66.7% for the RFA and HAFA group respectively, p=0.53) Symptomatic improvement was similar at 1 year between groups (81% vs 77.4% for HAFA vs RFA respectively, p=0.76). Conclusions: Combined cryoballoon and catheter ablation for LA substrate modification (HAFA) has similar safety and efficacy compared to stand-alone catheter ablation for persistent AF. Recurrent atrial flutter is more frequently observed after cryoballoon ablation for persistent AF.


Related Articles

  • Catheter-Based Ablation of Atrial Fibrillation. Ganjehei, Leila; Razavi, Mehdi; Rasekh, Abdi // Texas Heart Institute Journal;2011, Vol. 38 Issue 4, p361 

    The article discusses catheter-based radiofrequency ablation as a treatment for atrial fibrillation (AF), a common sustained cardiac arrhythmia. AF is caused by a rapidly firing focus in one of the atria which maintains the AF through short reentrant circuits thereby, causing spiraling...

  • Magnetically guided irrigated gold-tip catheter ablation of persistent atrial fibrillation-techniques, procedural parameters and outcome. Muntean, Bogdan; Gutleben, Klaus-Jürgen; Heintze, Johannes; Vogt, Jürgen; Horstkotte, Dieter; Nölker, Georg // Journal of Interventional Cardiac Electrophysiology;Nov2012, Vol. 35 Issue 2, p163 

    Purpose: Magnetically guided irrigated ablation has been introduced for atrial fibrillation (AF) ablation. However, data on ablation of persistent AF is scarce, and first-generation platinum-iridium catheters were burdened by char formation at the catheter tip. Furthermore, energy transmission...

  • Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation. Wilber, David J.; Pappone, Carlo; Neuzil, Petr; De Paola, Angelo; Marchlinski, Frank; Natale, Andrea; Macle, Laurent; Daoud, Emile G.; Calkins, Hugh; Hall, Burr; Reddy, Vivek; Augello, Giuseppe; Reynolds, Matthew R.; Vinekar, Chandan; Liu, Christine Y.; Berry, Scott M.; Berry, Donald A. // JAMA: Journal of the American Medical Association;1/27/2010, Vol. 303 Issue 4, p333 

    The article focuses on a prospective, multicenter, randomized unblinded, Bayesian-designed study which determined the efficacy of catheter ablation compared with antiarrhythmic drug therapy (ADT) in treating symptomatic paroxysmal atrial fibrillation (AF). The study was conducted in 19 hospitals...

  • The Surgical Treatment for Atrial Fibrillation: Ablation Technology and Surgical Approaches. Henry, Linda; Ad, Niv // Rambam Maimonides Medical Journal;Jul2013, Vol. 4 Issue 3, p1 

    The Cox maze procedure developed originally in 1987 by Dr James Cox has evolved from a "cut and sew" surgical procedure, where the maze was applied using multiple surgical cuts, to an extensive use of surgical ablation technology where ablation lesions are placed with alternative energy sources...

  • Current practice and recent advances in catheter ablation. Lee, Justin; Bugden, Hilary; Grace, Andrew // British Journal of Cardiac Nursing;Jun2013, Vol. 8 Issue 6, p273 

    The use of invasive cardiac electrophysiology and radiofrequency catheter ablation in the diagnosis and treatment of arrhythmias has become a part of mainstream cardiology practice. Atrial flutter and supraventricular tachycardias can be cured with a high rate of success and low risks of...

  • Study shows men fare better in AF procedures than women. FORD, OMAR // Medical Device Daily;2/5/2010, Vol. 14 Issue 24, p1 

    The article discusses research on the effectiveness of catheter ablation for treating atrial fibrillation (AF) in men and women. It references a study by Andrea Natale and colleagues published in the February 2010 issue of "Heart Rhythm Journal." The study found that the failure rate of ablation...

  • Hybrid Therapy for Atrial Fibrillation: Where the Knife Meets the Catheter. Curnis, Antonio; Bisleri, Gianluigi; Bontempi, Luca; Salghetti, Francesca; Cerini, Manuel; Lipari, Alessandro; Pagnoni, Carlo; Vassanelli, Francesca; Muneretto, Claudio // JAFIB: Journal of Atrial Fibrillation;Jun/Jul2013, Vol. 6 Issue 1, p110 

    During the past decades there has been a consistent evolution of both surgical and catheter-based techniques for the treatment of stand-alone atrial fibrillation, as alternatives or in combination with anti-arrhythmic drugs. Transcatheter ablation has significantly improved outcomes, despite...

  • CardioFocus gets CE mark for its Endoscopic Ablation System.  // Medical Device Daily;7/9/2009, Vol. 13 Issue 130, p1 

    The article reports on the CE mark received by CardioFocus which allows the company to start the European marketing of the Endoscopic Ablation System (EAS) to treat patients with atrial fibrillation (AF). The EAS is a novel device that incorporates both a micro-endoscope and light energy fibers...

  • RCA has short-term benefits; still unclear over long-term results. FORD, OMAR // Medical Device Daily;7/9/2009, Vol. 13 Issue 130, p1 

    The article focuses on a report by the U.S. Dept. of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ) on the effectiveness of radio frequency catheter ablation (RCA) in treating atrial fibrillation (AF). According to the report, the procedure helps patients in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics